What is it about?
Type-2 diabetes mellitus accounts for 80-90% of diabetic patients. So far, the treatment of diabetes mainly aims at elevating insulin level and lowering glucose level in the peripheral blood and mitigating insulin resistance. Physiologically, insulin secretion from pancreatic β cells is delicately regulated. Thus, how insulin-related therapies could titrate blood glucose appropriately and avoid the occurrence of hypoglycemia remains an important issue for decades. Similar question is addressed on how to attenuate vascular complication in diabetic subjects
Featured Image
Why is it important?
We overviewed the evolution of each class of anti-diabetic drugs that have been used in clinical practice, focusing on their mechanisms, clinical results and cautions.
Read the Original
This page is a summary of: Fighting type-2 diabetes: present and future perspectives, Current Medicinal Chemistry, October 2017, Bentham Science Publishers,
DOI: 10.2174/0929867324666171009115356.
You can read the full text:
Contributors
The following have contributed to this page
